English
简体中文
Total: £ 56.28
Published Date: 2025-07-17 | Pages: 72 | Tables: 79 | Medical Care
The global market for Placental Exosome Therapy was valued at US$ 267 million in the year 2024 and is projected to reach a revised size of US$ 949 million by 2031, growing at a CAGR of 21.3% during the forecast period.
Placental exosome therapy is an exosome-based regenerative medicine therapy that uses exosomes extracted from the placenta for treatment or anti-aging.
North American market for Placental Exosome Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Placental Exosome Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Placental Exosome Therapy in Skin Rejuvenation is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Placental Exosome Therapy include Celularity, Japan Bio Products Co., Ltd., BioIVT, Pluristem, Creative Biolabs, Kimera Labs, ZenBio, Americord, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Placental Exosome Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Placental Exosome Therapy.
The Placental Exosome Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Placental Exosome Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Placental Exosome Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Celularity
Japan Bio Products Co., Ltd.
BioIVT
Pluristem
Creative Biolabs
Kimera Labs
ZenBio
Americord
Segment by Type
Drugs
Therapeutic Solutions
Segment by Application
Skin Rejuvenation
Hair Restoration
Wound Healing
Cardiovascular Disease
Premature Ovarian Failure
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Placental Exosome Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Placental Exosome Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drugs
1.2.3 Therapeutic Solutions
1.3 Market by Application
1.3.1 Global Placental Exosome Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Skin Rejuvenation
1.3.3 Hair Restoration
1.3.4 Wound Healing
1.3.5 Cardiovascular Disease
1.3.6 Premature Ovarian Failure
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Placental Exosome Therapy Market Perspective (2020-2031)
2.2 Global Placental Exosome Therapy Growth Trends by Region
2.2.1 Global Placental Exosome Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Placental Exosome Therapy Historic Market Size by Region (2020-2025)
2.2.3 Placental Exosome Therapy Forecasted Market Size by Region (2026-2031)
2.3 Placental Exosome Therapy Market Dynamics
2.3.1 Placental Exosome Therapy Industry Trends
2.3.2 Placental Exosome Therapy Market Drivers
2.3.3 Placental Exosome Therapy Market Challenges
2.3.4 Placental Exosome Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Placental Exosome Therapy Players by Revenue
3.1.1 Global Top Placental Exosome Therapy Players by Revenue (2020-2025)
3.1.2 Global Placental Exosome Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top Placental Exosome Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Placental Exosome Therapy Revenue
3.4 Global Placental Exosome Therapy Market Concentration Ratio
3.4.1 Global Placental Exosome Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Placental Exosome Therapy Revenue in 2024
3.5 Global Key Players of Placental Exosome Therapy Head office and Area Served
3.6 Global Key Players of Placental Exosome Therapy, Product and Application
3.7 Global Key Players of Placental Exosome Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Placental Exosome Therapy Breakdown Data by Type
4.1 Global Placental Exosome Therapy Historic Market Size by Type (2020-2025)
4.2 Global Placental Exosome Therapy Forecasted Market Size by Type (2026-2031)
5 Placental Exosome Therapy Breakdown Data by Application
5.1 Global Placental Exosome Therapy Historic Market Size by Application (2020-2025)
5.2 Global Placental Exosome Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Placental Exosome Therapy Market Size (2020-2031)
6.2 North America Placental Exosome Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Placental Exosome Therapy Market Size by Country (2020-2025)
6.4 North America Placental Exosome Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Placental Exosome Therapy Market Size (2020-2031)
7.2 Europe Placental Exosome Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Placental Exosome Therapy Market Size by Country (2020-2025)
7.4 Europe Placental Exosome Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Placental Exosome Therapy Market Size (2020-2031)
8.2 Asia-Pacific Placental Exosome Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Placental Exosome Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Placental Exosome Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Placental Exosome Therapy Market Size (2020-2031)
9.2 Latin America Placental Exosome Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Placental Exosome Therapy Market Size by Country (2020-2025)
9.4 Latin America Placental Exosome Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Placental Exosome Therapy Market Size (2020-2031)
10.2 Middle East & Africa Placental Exosome Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Placental Exosome Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Placental Exosome Therapy Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Celularity
11.1.1 Celularity Company Details
11.1.2 Celularity Business Overview
11.1.3 Celularity Placental Exosome Therapy Introduction
11.1.4 Celularity Revenue in Placental Exosome Therapy Business (2020-2025)
11.1.5 Celularity Recent Development
11.2 Japan Bio Products Co., Ltd.
11.2.1 Japan Bio Products Co., Ltd. Company Details
11.2.2 Japan Bio Products Co., Ltd. Business Overview
11.2.3 Japan Bio Products Co., Ltd. Placental Exosome Therapy Introduction
11.2.4 Japan Bio Products Co., Ltd. Revenue in Placental Exosome Therapy Business (2020-2025)
11.2.5 Japan Bio Products Co., Ltd. Recent Development
11.3 BioIVT
11.3.1 BioIVT Company Details
11.3.2 BioIVT Business Overview
11.3.3 BioIVT Placental Exosome Therapy Introduction
11.3.4 BioIVT Revenue in Placental Exosome Therapy Business (2020-2025)
11.3.5 BioIVT Recent Development
11.4 Pluristem
11.4.1 Pluristem Company Details
11.4.2 Pluristem Business Overview
11.4.3 Pluristem Placental Exosome Therapy Introduction
11.4.4 Pluristem Revenue in Placental Exosome Therapy Business (2020-2025)
11.4.5 Pluristem Recent Development
11.5 Creative Biolabs
11.5.1 Creative Biolabs Company Details
11.5.2 Creative Biolabs Business Overview
11.5.3 Creative Biolabs Placental Exosome Therapy Introduction
11.5.4 Creative Biolabs Revenue in Placental Exosome Therapy Business (2020-2025)
11.5.5 Creative Biolabs Recent Development
11.6 Kimera Labs
11.6.1 Kimera Labs Company Details
11.6.2 Kimera Labs Business Overview
11.6.3 Kimera Labs Placental Exosome Therapy Introduction
11.6.4 Kimera Labs Revenue in Placental Exosome Therapy Business (2020-2025)
11.6.5 Kimera Labs Recent Development
11.7 ZenBio
11.7.1 ZenBio Company Details
11.7.2 ZenBio Business Overview
11.7.3 ZenBio Placental Exosome Therapy Introduction
11.7.4 ZenBio Revenue in Placental Exosome Therapy Business (2020-2025)
11.7.5 ZenBio Recent Development
11.8 Americord
11.8.1 Americord Company Details
11.8.2 Americord Business Overview
11.8.3 Americord Placental Exosome Therapy Introduction
11.8.4 Americord Revenue in Placental Exosome Therapy Business (2020-2025)
11.8.5 Americord Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Placental Exosome Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drugs
Table 3. Key Players of Therapeutic Solutions
Table 4. Global Placental Exosome Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Placental Exosome Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Placental Exosome Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Placental Exosome Therapy Market Share by Region (2020-2025)
Table 8. Global Placental Exosome Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Placental Exosome Therapy Market Share by Region (2026-2031)
Table 10. Placental Exosome Therapy Market Trends
Table 11. Placental Exosome Therapy Market Drivers
Table 12. Placental Exosome Therapy Market Challenges
Table 13. Placental Exosome Therapy Market Restraints
Table 14. Global Placental Exosome Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Placental Exosome Therapy Market Share by Players (2020-2025)
Table 16. Global Top Placental Exosome Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Exosome Therapy as of 2024)
Table 17. Ranking of Global Top Placental Exosome Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Placental Exosome Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Placental Exosome Therapy, Headquarters and Area Served
Table 20. Global Key Players of Placental Exosome Therapy, Product and Application
Table 21. Global Key Players of Placental Exosome Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Placental Exosome Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Placental Exosome Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Placental Exosome Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Placental Exosome Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Placental Exosome Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Placental Exosome Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Placental Exosome Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Placental Exosome Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Placental Exosome Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Placental Exosome Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Placental Exosome Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Placental Exosome Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Placental Exosome Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Placental Exosome Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Placental Exosome Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Placental Exosome Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Placental Exosome Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Placental Exosome Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Placental Exosome Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Placental Exosome Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Placental Exosome Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Placental Exosome Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Placental Exosome Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Celularity Company Details
Table 47. Celularity Business Overview
Table 48. Celularity Placental Exosome Therapy Product
Table 49. Celularity Revenue in Placental Exosome Therapy Business (2020-2025) & (US$ Million)
Table 50. Celularity Recent Development
Table 51. Japan Bio Products Co., Ltd. Company Details
Table 52. Japan Bio Products Co., Ltd. Business Overview
Table 53. Japan Bio Products Co., Ltd. Placental Exosome Therapy Product
Table 54. Japan Bio Products Co., Ltd. Revenue in Placental Exosome Therapy Business (2020-2025) & (US$ Million)
Table 55. Japan Bio Products Co., Ltd. Recent Development
Table 56. BioIVT Company Details
Table 57. BioIVT Business Overview
Table 58. BioIVT Placental Exosome Therapy Product
Table 59. BioIVT Revenue in Placental Exosome Therapy Business (2020-2025) & (US$ Million)
Table 60. BioIVT Recent Development
Table 61. Pluristem Company Details
Table 62. Pluristem Business Overview
Table 63. Pluristem Placental Exosome Therapy Product
Table 64. Pluristem Revenue in Placental Exosome Therapy Business (2020-2025) & (US$ Million)
Table 65. Pluristem Recent Development
Table 66. Creative Biolabs Company Details
Table 67. Creative Biolabs Business Overview
Table 68. Creative Biolabs Placental Exosome Therapy Product
Table 69. Creative Biolabs Revenue in Placental Exosome Therapy Business (2020-2025) & (US$ Million)
Table 70. Creative Biolabs Recent Development
Table 71. Kimera Labs Company Details
Table 72. Kimera Labs Business Overview
Table 73. Kimera Labs Placental Exosome Therapy Product
Table 74. Kimera Labs Revenue in Placental Exosome Therapy Business (2020-2025) & (US$ Million)
Table 75. Kimera Labs Recent Development
Table 76. ZenBio Company Details
Table 77. ZenBio Business Overview
Table 78. ZenBio Placental Exosome Therapy Product
Table 79. ZenBio Revenue in Placental Exosome Therapy Business (2020-2025) & (US$ Million)
Table 80. ZenBio Recent Development
Table 81. Americord Company Details
Table 82. Americord Business Overview
Table 83. Americord Placental Exosome Therapy Product
Table 84. Americord Revenue in Placental Exosome Therapy Business (2020-2025) & (US$ Million)
Table 85. Americord Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. Placental Exosome Therapy Picture
Figure 2. Global Placental Exosome Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Placental Exosome Therapy Market Share by Type: 2024 VS 2031
Figure 4. Drugs Features
Figure 5. Therapeutic Solutions Features
Figure 6. Global Placental Exosome Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Placental Exosome Therapy Market Share by Application: 2024 VS 2031
Figure 8. Skin Rejuvenation Case Studies
Figure 9. Hair Restoration Case Studies
Figure 10. Wound Healing Case Studies
Figure 11. Cardiovascular Disease Case Studies
Figure 12. Premature Ovarian Failure Case Studies
Figure 13. Others Case Studies
Figure 14. Placental Exosome Therapy Report Years Considered
Figure 15. Global Placental Exosome Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Placental Exosome Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Placental Exosome Therapy Market Share by Region: 2024 VS 2031
Figure 18. Global Placental Exosome Therapy Market Share by Players in 2024
Figure 19. Global Placental Exosome Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Placental Exosome Therapy Revenue in 2024
Figure 21. North America Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Placental Exosome Therapy Market Share by Country (2020-2031)
Figure 23. United States Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Placental Exosome Therapy Market Share by Country (2020-2031)
Figure 27. Germany Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Ireland Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Placental Exosome Therapy Market Share by Region (2020-2031)
Figure 35. China Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia & New Zealand Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Placental Exosome Therapy Market Share by Country (2020-2031)
Figure 43. Mexico Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Placental Exosome Therapy Market Share by Country (2020-2031)
Figure 47. Israel Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Placental Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Celularity Revenue Growth Rate in Placental Exosome Therapy Business (2020-2025)
Figure 51. Japan Bio Products Co., Ltd. Revenue Growth Rate in Placental Exosome Therapy Business (2020-2025)
Figure 52. BioIVT Revenue Growth Rate in Placental Exosome Therapy Business (2020-2025)
Figure 53. Pluristem Revenue Growth Rate in Placental Exosome Therapy Business (2020-2025)
Figure 54. Creative Biolabs Revenue Growth Rate in Placental Exosome Therapy Business (2020-2025)
Figure 55. Kimera Labs Revenue Growth Rate in Placental Exosome Therapy Business (2020-2025)
Figure 56. ZenBio Revenue Growth Rate in Placental Exosome Therapy Business (2020-2025)
Figure 57. Americord Revenue Growth Rate in Placental Exosome Therapy Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
